Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James D. Smith
Observed names:
James D Smith,
James Smith,
Smith, James D.
Institution:
Boehringer Ingelheim (United States)
Observed institutions:
Oregon Health & Science University,
South London and Maudsley NHS Foundation Trust,
Boehringer Ingelheim (United States),
Government of New York City,
University of Arkansas at Fayetteville
ORCID:
0000-0001-5978-4717
Observed ORCID:
0000-0001-5978-4717
OpenAlex ID:
A5101788170
Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK
2021
·
R Asaad Baksh
, Sarah E Pape
, et al.
·
BMJ Open
·
59
PDF
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 2, optimization for blood pressure reduction in spontaneously hypertensive rats
2010
·
John D. Ginn
, Todd Bosanac
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
23
A Predominant Oxidative Renal Metabolite of Empagliflozin in Male Mice Is Cytotoxic in Mouse Renal Tubular Cells but not Genotoxic
2017
·
James D. Smith
, Zimei Huang
, et al.
·
International Journal of Toxicology
·
12
PDF
Identification of sperm mRNA biomarkers associated with testis injury during preclinical testing of pharmaceutical compounds
2017
·
Edward Dere
, Daniel J. Spade
, et al.
·
Toxicology and Applied Pharmacology
·
8
Mode of action and human relevance assessment of male CD‐1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozin
2022
·
Jonathan A. Phillips
, Mitchell E. Taub
, et al.
·
Journal of Applied Toxicology
·
7
Non-neutralizing antibodies increase endogenous circulating Ang1 levels
2018
·
Chao Zheng
, Joshuaine Toth
, et al.
·
mAbs
·
7
Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices With Case Study Examples
2024
·
Smita Salian-Mehta
, James D. Smith
, et al.
·
International Journal of Toxicology
·
5
The use of emerging safety biomarkers in nonclinical and clinical safety assessment – The current and future state: An IQ DruSafe industry survey
2020
·
Tanja S. Zabka
, John Burkhardt
, et al.
·
Regulatory Toxicology and Pharmacology
·
5
PDF
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers
2017
·
Liuxi Chen
, James Smith
, et al.
·
Chemical Research in Toxicology
·
4
Drug safety Africa: An overview of safety pharmacology & toxicology in South Africa
2019
·
Brian D. Guth
, Anne F. Grobler
, et al.
·
Journal of Pharmacological and Toxicological Methods
·
2
PDF
Critical Thinking in Medical Education Missions
2019
·
J. Dwight Phillips
, Mary Hermiz
, et al.
·
Christian Journal for Global Health
·
1
Comparison of Smear, Culture and Complement Fixation in Chronic Gonorrhoea in Women
1920
·
James D Smith
, M A Wilson
·
The Journal of Immunology
·
1
Featured Cover
2022
·
Jonathan A. Phillips
, Mitchell E. Taub
, et al.
·
Journal of Applied Toxicology
The use of emerging safety biomarkers in nonclinical and clinical safety assessment—the current and future state: An IQ DruSafe industry survey
2020
·
Tanja S. Zabka
, John Burkhardt
, et al.
·
Journal of Pharmacological and Toxicological Methods
Hypocholesterolemic effects of soyasaponins and soyasapogenol B
2011
·
James D Smith
, Joe Salyer
, et al.
·
The FASEB Journal
Show more works
View as search
Works count:
18
Citation count:
144
H-index:
6
I10-index:
3
Year
Topic
Type